TRILLIUM THERAPEUTICS INC - COM NEW

CUSIP: 89620X506

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM NEW
Total 13F shares
2,341,035
Share change
-306,657
Total reported value
$14,423,111
Price per share
$6.15
Number of holders
21
Value change
-$1,714,679
Number of buys
10
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 89620X506?
CUSIP 89620X506 identifies 89620X506 - TRILLIUM THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TRILLIUM THERAPEUTICS INC - COM NEW as of Q1 2017

As of 31 Mar 2017, TRILLIUM THERAPEUTICS INC - COM NEW was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,341,035 shares. The largest 10 holders included JANUS CAPITAL MANAGEMENT LLC, BAKER BROS. ADVISORS LP, FRANKLIN RESOURCES INC, venBio Select Advisor LLC, INTERNATIONAL BIOTECHNOLOGY TRUST PLC, Sectoral Asset Management Inc, Candriam Luxembourg S.C.A., New Leaf Venture Partners, L.L.C., VICTORY CAPITAL MANAGEMENT INC, and Creative Planning. This page lists 21 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.